De Zhou
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Autoimmune and Inflammatory Disorders Research
- Platelet Disorders and Treatments
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Papers in
- Hematology 29
- Acute Myeloid Leukemia Research 15
- Autoimmune and Inflammatory Disorders Research 11
-
- Lymphoma Diagnosis and Treatment 13
- Co-authors
- Xiujin Ye (32 shared papers)Wanzhuo Xie (41 shared papers)Lixia Zhu (28 shared papers)Jianai Sun (18 shared papers)Mixue Xie (17 shared papers)Jingjing Zhu (18 shared papers)Jie Jin (16 shared papers)Mingyu Zhu (9 shared papers)
- Journals
- Frontiers in Oncology (3 papers)British Journal of Haematology (3 papers)Oncotarget (3 papers)Blood Cancer Journal (3 papers)Blood (2 papers)
- Partner nations
- China
In The Last Decade
De Zhou
52 papers receiving 590 citations
Peers
Comparison fields: 5 of 50
- Hematology 325
- Pathology and Forensic Medicine 91
- Endocrinology 14
- Oncology 60
- Neurology 21
Countries citing papers authored by De Zhou
This map shows the geographic impact of De Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by De Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites De Zhou more than expected).
Fields of papers citing papers by De Zhou
This network shows the impact of papers produced by De Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by De Zhou. The network helps show where De Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside De Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 85 | |
| 2 | 2017 | 39 | |
| 3 | 2020 | 36 | |
| 4 | 2019 | 32 | |
| 5 | 2018 | 27 | |
| 6 | 2022 | 26 | |
| 7 | 2016 | 22 | |
| 8 | 2021 | 18 | |
| 9 | 2021 | 16 | |
| 10 | 2013 | 15 | |
| 11 | 2013 | 15 | |
| 12 | 2017 | 15 | |
| 13 | 2018 | 15 | |
| 14 | 2024 | 15 | |
| 15 | Replacement of conventional doxorubicin by pegylated liposomal doxorubicin in standard RCHOP chemotherapy for elderly diffuse large B-Cell lymphoma: a retrospective study in China. | 2015 | 14 |
| 16 | 2022 | 14 | |
| 17 | 2012 | 13 | |
| 18 | 2019 | 13 | |
| 19 | 2020 | 13 | |
| 20 | 2017 | 12 |
About De Zhou
De Zhou is a scholar working on Hematology, Pathology and Forensic Medicine, Oncology, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine, having authored 56 papers that have together received 597 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (15 papers), Lymphoma Diagnosis and Treatment (13 papers), Autoimmune and Inflammatory Disorders Research (11 papers), Acute Lymphoblastic Leukemia research (4 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), Retinoids in leukemia and cellular processes (2 papers), Viral-associated cancers and disorders (2 papers) and Neutropenia and Cancer Infections (2 papers). The work is most often cited by research in Hematology (325 citations), Pathology and Forensic Medicine (91 citations), Endocrinology (14 citations), Oncology (60 citations) and Neurology (21 citations). De Zhou has collaborated with scholars based in China. Frequent co-authors include Xiujin Ye, Wanzhuo Xie, Lixia Zhu, Jianai Sun, Mixue Xie, Jingjing Zhu, Jie Jin, Mingyu Zhu, Xianbo Huang and Rongrong Chen. Their work appears in journals such as Frontiers in Oncology, British Journal of Haematology, Oncotarget, Blood Cancer Journal and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.